微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 4.34% | 41.83% | -15.89% | 14/68 | 2.31% | 羚锐制药 | 6.99% | 行业排名> |
| 2025-12-31 | 5.16% | 7.5% | 25.55% | 33/68 | 2.77% | 羚锐制药 | 22.39% | 行业排名> |
| 2025-09-30 | 4.11% | -33.6% | 13.22% | 38/68 | 4.88% | 达仁堂 | 25.38% | 行业排名> |
| 2025-06-30 | 3.63% | -24.06% | 18.63% | 32/68 | 3.21% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 3.06% | -14.76% | -36.25% | 21/68 | 2.25% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 4.8% | -30.33% | -22.46% | 35/68 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 6.19% | -14.62% | 29.5% | 29/68 | 5.46% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 4.78% | -18.01% | 33.15% | 23/68 | 2.54% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 3.59% | -9.8% | -47.9% | 19/68 | 1.97% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 6.89% | 129.67% | -4.97% | 35/68 | 2.03% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 7.25% | -25.03% | 24.36% | 33/68 | 7.62% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 5.83% | 82.19% | 46.48% | 24/68 | 5.2% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 3.98% | 29.64% | 32.67% | 20/68 | 3.31% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 3% | -51.22% | -68.98% | 49/68 | 6.79% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 9.67% | 41.37% | 202.19% | 19/68 | 5.19% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 3.2% | -33.47% | 4.23% | 40/68 | 3.33% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 3.07% | 15.41% | -50.08% | 21/68 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 6.15% | -3.45% | -10.09% | 37/68 | 4.51% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 6.84% | 18.54% | 42.2% | 37/68 | 7.47% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 4.81% | 1.05% | 80.83% | 29/68 | 4.6% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 2.66% | 20.36% | -58.24% | 29/68 | 2.63% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 6.37% | 69.41% | 10.4% | 38/68 | 0.07% | 长药退 | 7.37% | 行业排名> |
| 2020-09-30 | 5.77% | 26.81% | 21.22% | 36/68 | 6.89% | 以岭药业 | 7.15% | 行业排名> |
| 2020-06-30 | 4.76% | 31.86% | 115.38% | 24/68 | 3.83% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | 2.21% | 16.32% | -41.22% | 29/68 | 2.18% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | 3.76% | -35.17% | -17.36% | 47/68 | 6.88% | 沃华医药 | 12.7% | 行业排名> |
| 2019-09-30 | 4.55% | -37.93% | 26.04% | 44/68 | 7.39% | 济川药业 | 7.33% | 行业排名> |
| 2019-06-30 | 3.61% | -41.01% | 90% | 43/68 | 4.75% | 济川药业 | 27.43% | 行业排名> |
| 2019-03-31 | 1.9% | -38.91% | -67.24% | 45/68 | 2.94% | 济川药业 | 23.05% | 行业排名> |
| 2018-12-31 | 5.8% | -61.89% | -20.87% | 45/68 | 7.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-09-30 | 7.33% | -34.2% | 19.77% | 34/68 | 8.02% | 华润三九 | 10.23% | 行业排名> |
| 2018-06-30 | 6.12% | -23.31% | 96.78% | 26/68 | 5.05% | 济川药业 | 32.79% | 行业排名> |
| 2018-03-31 | 3.11% | -1.58% | -79.57% | 25/68 | 2.78% | 济川药业 | 27.55% | 行业排名> |
| 2017-12-31 | 15.22% | -2.06% | 36.62% | 14/68 | 9.95% | 济川药业 | 17.62% | 行业排名> |
| 2017-09-30 | 11.14% | -6.7% | 39.6% | 18/68 | 8.4% | 济川药业 | 10.07% | 行业排名> |
| 2017-06-30 | 7.98% | 11.76% | 152.53% | 13/68 | 5.23% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-03-31 | 3.16% | -7.06% | -79.67% | 24/68 | 2.66% | 济川药业 | 24.2% | 行业排名> |
| 2016-12-31 | 15.54% | -47.43% | 30.15% | 15/68 | 10.19% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 11.94% | 101.35% | 67.23% | 14/68 | 9.47% | 济川药业 | 14.64% | 行业排名> |
| 2016-06-30 | 7.14% | 61.17% | 110% | 22/68 | 5.15% | 济川药业 | 7.64% | 行业排名> |
| 2016-03-31 | 3.4% | -55.73% | -88.5% | 24/68 | 4.17% | 维康药业 | 38.23% | 行业排名> |